Phase I/II trial of a cox-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: Radiation therapy oncology group 0213

Elizabeth Gore, Kyounghwa Bae, Corey Langer, Martine Extermann, Benjamin Movsas, Paul Okunieff, Gregory Videtic, Hak Choy

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'Phase I/II trial of a cox-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: Radiation therapy oncology group 0213'. Together they form a unique fingerprint.

Medicine & Life Sciences